← SynDRA
HALOPROGIN
SynDRA canonical compound SYN0005064 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | other antifungal |
|---|
| Indication | tinea pedis |
|---|
| Disease area | infectious disease |
|---|
All known targets
- ADORA3
- ADRA2A
- ADRA2B
- ADRA2C
- DRD1
- DRD3
- GALE
- HTR2A
- HTR2C
- HTR6
- OPRK1
- SLC6A2
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ESR1
- KCNH2
- MAOA
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- ACHE
- LCK
- NPY1R
- KAT2A
- HTR2B
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- KDR
- NPY2R
- GMNN
- NR3C1
- VDR
- TDP1
- TBXAS1
- TBXA2R
- TACR1
- SIGMAR1
- SAMHD1
- PTPRC
- PTGS2
- PTGS1
- PTAFR
- PRKCA
- PPP3CA
- PGR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP19A
- CP2C9
- CP2D6
- CP3A7
- FURIN
- GCR
- GEMI
- TP53
Drug classes
- Anti-Infective Agents
- Antifungal Agents
- other antifungal
ATC classes
- D01A · ANTIFUNGALS FOR TOPICAL USE
Cross-references
Synonyms
- HALOTEX
- haloprogine
- Haloprogine
- Haloprogina
- M-1028
- M-1028 (MEIJI)
- NSC-100071
- Halotex
- Mycanden
- Aloprogen
- Haloproginum
- Mycilan
- Polik
- Component of Halotex
- M 1028
- Haloprogina [INN-Spanish]
- Haloprogine [INN-French]
- Haloproginum [INN-Latin]
- Halotex (TN)
- Mycanden (TN)
- Mycilan (TN)
- Polik (TN)
- Haloprogin [USAN:INN:JAN]
- M-1028 (Meiji)
- Haloprogin (JAN/USAN/INN)
- 1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene
- 2,4,5-Trichlorophenyl gamma-iodopropargil ether
- 2,4,5-Trichlorophenyl iodopropargyl ether
- 2,4,5-Trichlorophenyl-gamma-iodopropargyl ether
- NSC 100071
- AIU7053OWL
- NSC100071
- DTXCID7026865
- aloprogin
- RefChem:57121
- D01AE11
- NCGC00181134-01
- component of Halotex
Look up HALOPROGIN in the interactive SynDRA portal →